
HBANM · Nasdaq
There is no published sell-side consensus for HBANM: the supplied dataset lists zero analysts, with no consensus rating and no low, mean, or high price target. Consequently, no target cluster, target spread, most-bullish analyst, least-bullish analyst, or weekly revision direction can be identified. No named investment bank or research analyst issued a rating or target change during the week. The only substantive directional disagreement in the evidence comes from Stock Traders Daily’s technical commentary rather than conventional analyst coverage: one item describes a 2.8% upside setup with limited stated risk, while another suggests a short near $23.52 with a $22.44 downside target. That divergence does not establish a sell-side view.